Early research (Phase 1)Study completedNCT00423254
What this trial is testing
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
Who this might be right for
OvarianMelanomaRenal+20 more
Mannkind Corporation 12